Vaxcyte Doses First Participants in Phase 1/2 Clinical Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults
— Company Expects to Announce Topline Results from the Phase 1/2 Study by the End of…
Month: February 2022
Orphazyme announces update on regulatory review of arimoclomol in the European Union
Orphazyme A/SCompany announcementNo. 07/2022Inside informationwww.orphazyme.comCompany Registration No. 32266355 Copenhagen, Denmark, February 23, 2022 – Orphazyme…
Cytek Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results
2021 Revenue Increased 38% Compared to Prior Year FREMONT, Calif., Feb. 23, 2022 (GLOBE NEWSWIRE)…
Mary Agrotechnologies Inc. Reports First Quarter Fiscal 2022 Financial Results
Markham, Ontario–(Newsfile Corp. – February 23, 2022) – Mary Agrotechnologies Inc. (CSE: MARY) (OTCQB: MRRYF)…
Hyliion Holdings Reports Fourth Quarter and Full Year 2021 Financial Results
AUSTIN, Texas–(BUSINESS WIRE)–Hyliion Holdings Corp. (NYSE: HYLN) (“Hyliion”), a leader in electrified powertrain solutions for…
MVIS Announces February 2022 Monthly Index Review Results of MVIS CryptoCompare Digital Assets Indices
FRANKFURT, Germany–(BUSINESS WIRE)–MV Index Solutions GmbH (MVIS®) today announced the results of the monthly MVIS…
Filing of the 2021 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report
Filing of the 2021 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual…
Allogene Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
AlloCAR T™ Studies Resumed and Currently Enrolling Patients Following Removal of Clinical Hold in January…
Insulet Reports Full Year 2021 Revenue Increase of 21% and Fourth Quarter 2021 Revenue Increase of 25% Year-Over-Year
Represents 6th Consecutive Year of Over 20% Revenue Growth; Annual Revenue Surpasses $1 Billion Omnipod…
Personalis to Present at the Cowen 42nd Annual Health Care Conference
MENLO PARK, Calif.–(BUSINESS WIRE)–Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced…
STAAR Surgical Reports Fourth Quarter and Full Year 2021 Results
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of…
Perimeter Medical Imaging AI Provides Corporate Update
Live Call/Webcast Today at 5 pm ET TORONTO & DALLAS–(BUSINESS WIRE)–$PINK.V #AI–Perimeter Medical Imaging AI,…
NetApp Reports Third Quarter of Fiscal Year 2022 Results
Net revenues for the third quarter grew 10% year-over-year to $1.61 billion NetApp™ Public Cloud…
McGrath RentCorp Announces Results for Fourth Quarter 2021
Company Announces 5% Dividend Increase LIVERMORE, Calif.–(BUSINESS WIRE)–McGrath RentCorp (NASDAQ: MGRC) (the “Company”), a diversified…
BELLUS Health Reports Year 2021 Financial Results and Business Highlights
– Announced positive topline results from the Phase 2b SOOTHE clinical trial in refractory chronic…
Notice Concerning Application for Partial Revision of Manufacturing and Marketing Approval of Companion Diagnostic Reagent for the AmoyDx® Pan Lung Cancer PCR Panel
TOKYO and XIAMEN, China, Feb. 23, 2022 (GLOBE NEWSWIRE) — Riken Genesis Co., Ltd., Amoy…
Adocia announces 2021 fourth quarter financial results
LYON, France, Feb. 23, 2022 (GLOBE NEWSWIRE) — Adocia (Euronext Paris: FR0011184241 – ADOC), a…
LIDDS AB (publ) Year-end report 2021
October – December Net sales amounted to 2.4 (0.3) MSEK The operating result for the…
Climate Change Breakthrough: New Research Indicates Photosynthesis Enhanced Trees Grow Faster and Capture More Carbon
In a world first, Living Carbon releases whitepaper demonstrating the efficacy of a photosynthesis enhancement…
Healthy Extracts Set for Major Win in Multibillion Dollar Nutraceuticals Market with Ramping Sales of Clinically Proven Supplements for Heart & Brain Health
Picture 1 UBN ACTIVATE™ is clinically proven to enhance brain function, improve cognition, memory, focus,…